*****Off topic*****Thanks Uncle Mikey, but I won't follow BTGC. I'm looking for an elegant solution to cancer in general, NHL in particular and death overall. cdmaOne is an elegant solution [phrase pinched from the great one, Andrew Viterbi]. While a cellphone will sell for hundreds of dollars, cancer cures will sell for multithousands. Rituxan will sell for about $12 000 per treatment. It will cost IDEC about $500 to make it. Now THAT'S profit!
There are about quarter of a million people running around with wayward cells which will kill them who could benefit from Rituxan and ytrrium 90 labelled monoclonal antibodies. Plus 54 000 new prospects per year in USA with NHL.
Okay, that's all from me today. Sunny day! [note to self - wear hat and sunscreen..]
Mqurice
PS: on topic.
The next quarter from 30 Sept to 31 Dec will include heaps of handset sales, much more infrastructure, payments received, royalties coming in, more Globalstar revenue, some license fees, Eudora sales, WLL underway, ASICs blooming, Omnitracs still rapidly improving, so profits and revenues will be way up again. And that will be just the start. 1998 is going to be THE year. At last. No more getting to market. AT market at last.
As cdmaOne supply increases, prices will drop and TDMA/analog/GSM will get their last sales. But demand is huge, so it might take 3 or 4 years to get to 50% market share worldwide. |
